Finally, targeted therapies for triple-negative breast cancer

Posted by on June 4, 2016 9:06 am
Categories: health

Researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a distinct strategy influenced by the immune system and all three have real potential to extend the lives of women whose cancers have progressed after previous treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *